^
BIOMARKER:

ALK rearrangement + HER-2 mutation

i
Other names: Anaplastic Lymphoma Kinase, Anaplastic Lymphoma Kinase (Ki-1), CD246 Antigen, Mutant Anaplastic Lymphoma Kinase, ALK, ALK Receptor Tyrosine Kinase, Anaplastic Lymphoma Receptor Tyrosine Kinase, ALK Tyrosine Kinase Receptor, ERBB2, CD340, HER-2, HER2, NEU, NGL, V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2
Entrez ID:
News
Twitter
Trials
ALK rearrangement + HER-2 mutation
NSCLC
crizotinib
Resistant: C3 – Early Trials